Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells
- 1 December 2009
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 87 (6) , 919-926
Abstract
Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) preferentially triggers apoptosis in tumor cells versus normal cells. However, TRAIL alone is not effective in treating TRAIL-resistant tumors. We evaluated the effect of 180 enzyme inhibitors on TRAIL-induced apoptosis in human lung cancer H1299 cells, and found fluphenazine-N-2-chloroethane (a calmodulin (CaM) antagonist) sensitized TRAIL-induced apoptosis. Interestingly, in the presence of TRAIL, it increased caspase-8 binding to the Fas-associated death domain (FADD), but decreased binding of FADD-like interleukin-1β-converting enzyme inhibitory proteins (FLIPs). Additionally, its combination with TRAIL inhibited Akt phosphorylation. These results were consistently observed in cells treated with CaM siRNA. We suggested the blockade of CaM could sensitize lung cancer cells to TRAIL-induced apoptosis in at least 2 ways: (i) it can activate death-inducing signaling complex mediated apoptosis by inhibiting TRAIL-induced binding of FLIP and TRAIL-enhanced binding of caspase-8 to FADD; (ii) it can inhibit Akt phosphorylation, consequently leading to decreased expression of anti-apoptotic molecules such as FLIP and members of the inhibitor of apoptosis protein family. This study suggests the combination of CaM antagonists with TRAIL may have the therapeutic potential to overcome the resistance of lung cancers to apoptosis.Keywords
This publication has 25 references indexed in Scilit:
- Calmodulin modulates Akt activity in human breast cancer cell linesBreast Cancer Research and Treatment, 2008
- Calmodulin binding to the Fas‐Mediated death‐inducing signaling complex in cholangiocarcinoma cellsJournal of Cellular Biochemistry, 2007
- Impaired apoptosis in lymphoblasts from Alzheimer’s disease patients: Cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathwaysCellular and Molecular Life Sciences, 2007
- Calmodulin-mediated Activation of Akt Regulates Survival of c-Myc-overexpressing Mouse Mammary Carcinoma CellsJournal of Biological Chemistry, 2004
- Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosisCell Death & Differentiation, 2004
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Serine/Threonine Protein Kinases and ApoptosisExperimental Cell Research, 2000
- Caspases: the executioners of apoptosisBiochemical Journal, 1997
- Calmodulin: a potential target for cancer chemotherapeutic agents.Journal of Clinical Oncology, 1986
- Calmodulin Plays a Pivotal Role in Cellular RegulationScience, 1980